Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.35 |
| ▸ | RORC | P51449 | 8/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | G6PD | P11413 | 1/20 | 0.34 |
| ▸ | USP14 | P54578 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20086172 | 0.97 | KDM4E (0.38) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20089851 | 0.97 | KDM4E (0.40) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20086159 | 0.97 | KDM4E (0.40) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20086154 | 0.94 | KDM4E (0.40) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20086152 | 0.94 | KDM4E (0.40) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL24524218 | 0.87 | KDM4E (0.41) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20086150 | 0.87 | PTGER4 (0.35) | KDM4EATML3MBTL1PTGER4RORC | |
| SCHEMBL18347414 | 0.87 | KDM4E (0.47) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL25905707 | 0.87 | KDM4E (0.47) | KDM4EENPP3ATML3MBTL1PTGER4 | |
| SCHEMBL20086174 | 0.87 | KDM4E (0.48) | KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714694-B2 | Delayed fluorescence material and organic light emitting device having the delayed fluorescence material | Research & Business Foundation Sungkyunkwan University (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20180114924-A1 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DEVICE HAVING THE DELAYED FLUORESCENCE MATERIAL | Research & Business Foundation Sungkyunkwan University (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114924-A1 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DEVICE HAVING THE DELAYED FLUORESCENCE MATERIAL | GFPT1, ETFA, TFEB | KDM4E 2968/4885ENPP3 2716/4885ATM 1592/4885 |
| US-10714694-B2 | Delayed fluorescence material and organic light emitting device having the delayed fluorescence material | GFPT1, ETFA, TFEB | KDM4E 2968/4885ENPP3 2716/4885ATM 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.